Cite
HARVARD Citation
Xie, H. et al. (2023). The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non‐small cell lung cancer. Journal of cachexia, sarcopenia and muscle. 14 (2), pp. 869-878. [Online].